nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A5—Dactinomycin—ocular cancer	0.851	1	CbGbCtD
Norepinephrine—ADRA2A—Hemostasis—CDK2—ocular cancer	0.000107	0.000716	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—EP300—ocular cancer	0.000107	0.000714	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TFDP1—ocular cancer	0.000107	0.000713	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—E2F3—ocular cancer	0.000106	0.000707	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—GNAQ—ocular cancer	0.000106	0.000707	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—GNAQ—ocular cancer	0.000103	0.000691	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—GNA11—ocular cancer	0.000103	0.000691	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CDKN2B—ocular cancer	0.000103	0.000687	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MAML2—ocular cancer	0.000102	0.000683	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000102	0.000682	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—E2F3—ocular cancer	0.000102	0.000682	CbGpPWpGaD
Norepinephrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000101	0.000678	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—TP53—ocular cancer	0.000101	0.000673	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	9.9e-05	0.000661	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TFDP1—ocular cancer	9.84e-05	0.000658	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—GNAQ—ocular cancer	9.61e-05	0.000642	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TFDP1—ocular cancer	9.48e-05	0.000634	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—E2F3—ocular cancer	9.48e-05	0.000633	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—E2F1—ocular cancer	9.44e-05	0.000631	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MAML2—ocular cancer	9.31e-05	0.000622	CbGpPWpGaD
Norepinephrine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—ocular cancer	9.3e-05	0.000621	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—GNA11—ocular cancer	9.24e-05	0.000618	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MAML2—ocular cancer	9.22e-05	0.000616	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MAML2—ocular cancer	9.11e-05	0.000609	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—GNA11—ocular cancer	8.99e-05	0.000601	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—GNA11—ocular cancer	8.91e-05	0.000596	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TFDP1—ocular cancer	8.81e-05	0.000589	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	8.79e-05	0.000587	CbGpPWpGaD
Norepinephrine—PAH—Disease—HRAS—ocular cancer	8.74e-05	0.000584	CbGpPWpGaD
Norepinephrine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—ocular cancer	8.69e-05	0.00058	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MAML2—ocular cancer	8.62e-05	0.000576	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—GNA11—ocular cancer	8.62e-05	0.000576	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—GNAQ—ocular cancer	8.59e-05	0.000574	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MAML2—ocular cancer	8.48e-05	0.000567	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—HRAS—ocular cancer	8.39e-05	0.000561	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—GNAQ—ocular cancer	8.36e-05	0.000559	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—GNAQ—ocular cancer	8.29e-05	0.000554	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—GNA11—ocular cancer	8.12e-05	0.000543	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—GNA11—ocular cancer	8.05e-05	0.000538	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—GNAQ—ocular cancer	8.01e-05	0.000535	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—GNA11—ocular cancer	7.95e-05	0.000531	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—EP300—ocular cancer	7.93e-05	0.00053	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—HRAS—ocular cancer	7.82e-05	0.000523	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MAML2—ocular cancer	7.82e-05	0.000522	CbGpPWpGaD
Norepinephrine—PAH—Disease—AKT1—ocular cancer	7.71e-05	0.000515	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—GNAQ—ocular cancer	7.55e-05	0.000505	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MAML2—ocular cancer	7.53e-05	0.000503	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—GNA11—ocular cancer	7.52e-05	0.000502	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—GNAQ—ocular cancer	7.48e-05	0.0005	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HDAC1—ocular cancer	7.47e-05	0.000499	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—EP300—ocular cancer	7.41e-05	0.000495	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—GNA11—ocular cancer	7.4e-05	0.000494	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—GNAQ—ocular cancer	7.39e-05	0.000494	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GNA11—ocular cancer	7.3e-05	0.000488	CbGpPWpGaD
Norepinephrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—ocular cancer	7.05e-05	0.000471	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MAML2—ocular cancer	7e-05	0.000468	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—GNAQ—ocular cancer	6.99e-05	0.000467	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TGFB1—ocular cancer	6.89e-05	0.000461	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—GNAQ—ocular cancer	6.88e-05	0.00046	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—GNA11—ocular cancer	6.82e-05	0.000456	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HDAC1—ocular cancer	6.81e-05	0.000455	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GNAQ—ocular cancer	6.79e-05	0.000454	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HDAC1—ocular cancer	6.74e-05	0.000451	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CDKN2B—ocular cancer	6.7e-05	0.000448	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HDAC1—ocular cancer	6.66e-05	0.000445	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—GNA11—ocular cancer	6.57e-05	0.000439	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—AKT1—ocular cancer	6.46e-05	0.000432	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TGFB1—ocular cancer	6.44e-05	0.00043	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—GNAQ—ocular cancer	6.34e-05	0.000424	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HDAC1—ocular cancer	6.3e-05	0.000421	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HDAC1—ocular cancer	6.2e-05	0.000414	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—E2F1—ocular cancer	6.15e-05	0.000411	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—GNAQ—ocular cancer	6.11e-05	0.000408	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—GNA11—ocular cancer	6.11e-05	0.000408	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN2B—ocular cancer	6.1e-05	0.000408	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN2B—ocular cancer	6.05e-05	0.000404	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—EP300—ocular cancer	6.02e-05	0.000402	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN2B—ocular cancer	5.97e-05	0.000399	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HDAC1—ocular cancer	5.72e-05	0.000382	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MDM2—ocular cancer	5.7e-05	0.000381	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—GNAQ—ocular cancer	5.68e-05	0.000379	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TP53—ocular cancer	5.68e-05	0.000379	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN2B—ocular cancer	5.65e-05	0.000377	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—E2F1—ocular cancer	5.6e-05	0.000374	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN2B—ocular cancer	5.56e-05	0.000371	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—E2F1—ocular cancer	5.55e-05	0.000371	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HDAC1—ocular cancer	5.51e-05	0.000368	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—E2F1—ocular cancer	5.48e-05	0.000366	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—HRAS—ocular cancer	5.43e-05	0.000363	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TP53—ocular cancer	5.3e-05	0.000354	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—HRAS—ocular cancer	5.3e-05	0.000354	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TGFB1—ocular cancer	5.23e-05	0.00035	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CDKN1B—ocular cancer	5.21e-05	0.000348	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—E2F1—ocular cancer	5.18e-05	0.000346	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—AKT1—ocular cancer	5.15e-05	0.000344	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN2B—ocular cancer	5.12e-05	0.000342	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HDAC1—ocular cancer	5.12e-05	0.000342	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—E2F1—ocular cancer	5.1e-05	0.000341	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—HRAS—ocular cancer	5.07e-05	0.000339	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CCND1—ocular cancer	4.97e-05	0.000332	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	4.94e-05	0.00033	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—EP300—ocular cancer	4.92e-05	0.000329	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CDKN1A—ocular cancer	4.81e-05	0.000321	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—AKT1—ocular cancer	4.79e-05	0.00032	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—E2F1—ocular cancer	4.7e-05	0.000314	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—AKT1—ocular cancer	4.68e-05	0.000313	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN2B—ocular cancer	4.59e-05	0.000307	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—EP300—ocular cancer	4.57e-05	0.000306	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—E2F1—ocular cancer	4.53e-05	0.000303	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—AKT1—ocular cancer	4.48e-05	0.000299	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TP53—ocular cancer	4.31e-05	0.000288	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—E2F1—ocular cancer	4.21e-05	0.000281	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—HRAS—ocular cancer	4.12e-05	0.000275	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GNA11—ocular cancer	4.03e-05	0.000269	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MYC—ocular cancer	3.98e-05	0.000266	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TGFB1—ocular cancer	3.97e-05	0.000266	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GNAQ—ocular cancer	3.75e-05	0.00025	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MDM2—ocular cancer	3.71e-05	0.000248	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—AKT1—ocular cancer	3.64e-05	0.000243	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	3.45e-05	0.000231	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	3.39e-05	0.000227	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MDM2—ocular cancer	3.38e-05	0.000226	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	3.36e-05	0.000224	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MDM2—ocular cancer	3.35e-05	0.000224	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MDM2—ocular cancer	3.31e-05	0.000221	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TP53—ocular cancer	3.27e-05	0.000219	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CCND1—ocular cancer	3.24e-05	0.000216	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—HRAS—ocular cancer	3.14e-05	0.00021	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MDM2—ocular cancer	3.13e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	3.13e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—HRAS—ocular cancer	3.13e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	3.12e-05	0.000208	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	3.09e-05	0.000207	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—EP300—ocular cancer	3.09e-05	0.000206	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MDM2—ocular cancer	3.08e-05	0.000206	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—HRAS—ocular cancer	3.08e-05	0.000206	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	3.06e-05	0.000205	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	3.06e-05	0.000204	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	3.05e-05	0.000204	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	3.03e-05	0.000202	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.02e-05	0.000202	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1B—ocular cancer	3.02e-05	0.000202	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—EP300—ocular cancer	3e-05	0.000201	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AKT1—ocular cancer	2.99e-05	0.0002	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EP300—ocular cancer	2.98e-05	0.000199	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AKT1—ocular cancer	2.98e-05	0.000199	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CCND1—ocular cancer	2.95e-05	0.000197	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CCND1—ocular cancer	2.92e-05	0.000195	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	2.91e-05	0.000194	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CCND1—ocular cancer	2.88e-05	0.000193	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—EP300—ocular cancer	2.88e-05	0.000192	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	2.86e-05	0.000191	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	2.86e-05	0.000191	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	2.85e-05	0.000191	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MDM2—ocular cancer	2.84e-05	0.00019	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	2.83e-05	0.000189	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	2.83e-05	0.000189	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	2.82e-05	0.000188	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CDKN1A—ocular cancer	2.79e-05	0.000186	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	2.78e-05	0.000186	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—ocular cancer	2.78e-05	0.000186	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—ocular cancer	2.76e-05	0.000185	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	2.75e-05	0.000184	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	2.74e-05	0.000183	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CCND1—ocular cancer	2.73e-05	0.000182	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—ocular cancer	2.72e-05	0.000181	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EP300—ocular cancer	2.71e-05	0.000181	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EP300—ocular cancer	2.69e-05	0.00018	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CCND1—ocular cancer	2.69e-05	0.000179	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EP300—ocular cancer	2.65e-05	0.000177	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HRAS—ocular cancer	2.64e-05	0.000176	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	2.64e-05	0.000176	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	2.6e-05	0.000174	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	2.6e-05	0.000173	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—ocular cancer	2.6e-05	0.000173	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	2.59e-05	0.000173	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	2.57e-05	0.000172	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	2.57e-05	0.000172	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MDM2—ocular cancer	2.54e-05	0.00017	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	2.54e-05	0.00017	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	2.53e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EP300—ocular cancer	2.51e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	2.5e-05	0.000167	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CCND1—ocular cancer	2.48e-05	0.000165	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	2.47e-05	0.000165	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EP300—ocular cancer	2.47e-05	0.000165	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—EP300—ocular cancer	2.44e-05	0.000163	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	2.4e-05	0.00016	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	2.39e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—ocular cancer	2.36e-05	0.000158	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	2.36e-05	0.000158	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—ocular cancer	2.36e-05	0.000158	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—ocular cancer	2.34e-05	0.000157	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	2.34e-05	0.000156	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—ocular cancer	2.33e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	2.32e-05	0.000155	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—ocular cancer	2.31e-05	0.000155	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	2.31e-05	0.000154	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—ocular cancer	2.31e-05	0.000154	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	2.3e-05	0.000154	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EP300—ocular cancer	2.28e-05	0.000152	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	2.25e-05	0.00015	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CCND1—ocular cancer	2.22e-05	0.000148	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EP300—ocular cancer	2.2e-05	0.000147	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—ocular cancer	2.19e-05	0.000146	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	2.18e-05	0.000146	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—ocular cancer	2.15e-05	0.000144	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	2.15e-05	0.000144	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	2.14e-05	0.000143	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—ocular cancer	2.13e-05	0.000142	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	2.09e-05	0.000139	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EP300—ocular cancer	2.04e-05	0.000136	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRAS—ocular cancer	2.04e-05	0.000136	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—ocular cancer	1.99e-05	0.000133	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—ocular cancer	1.98e-05	0.000132	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—ocular cancer	1.94e-05	0.00013	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—ocular cancer	1.92e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—ocular cancer	1.91e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	1.91e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—ocular cancer	1.9e-05	0.000127	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—ocular cancer	1.87e-05	0.000125	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRAS—ocular cancer	1.86e-05	0.000124	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRAS—ocular cancer	1.84e-05	0.000123	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRAS—ocular cancer	1.82e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—ocular cancer	1.82e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—ocular cancer	1.8e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—ocular cancer	1.8e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—ocular cancer	1.78e-05	0.000119	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	1.77e-05	0.000119	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—ocular cancer	1.77e-05	0.000118	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—ocular cancer	1.74e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRAS—ocular cancer	1.72e-05	0.000115	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRAS—ocular cancer	1.69e-05	0.000113	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—ocular cancer	1.64e-05	0.00011	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—ocular cancer	1.63e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—ocular cancer	1.62e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—ocular cancer	1.6e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—ocular cancer	1.57e-05	0.000105	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRAS—ocular cancer	1.56e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—ocular cancer	1.52e-05	0.000101	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	1.5e-05	0.0001	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—ocular cancer	1.49e-05	9.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—ocular cancer	1.47e-05	9.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—ocular cancer	1.46e-05	9.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRAS—ocular cancer	1.4e-05	9.33e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—ocular cancer	1.38e-05	9.2e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—EP300—ocular cancer	1.35e-05	9e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	1.33e-05	8.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—ocular cancer	1.23e-05	8.24e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—ocular cancer	8.14e-06	5.44e-05	CbGpPWpGaD
